Rapid-Onset Psychotic Symptoms After Interferon-β-1a Treatment of Multiple Sclerosis

被引:0
|
作者
Huang, Jing-Syuan [1 ,2 ]
Chang, Chuan-Chia [2 ]
Tai, Yueh-Ming [1 ,2 ]
Huang, Chien-Peng [3 ]
Chen, Shyi-Jou [4 ]
Tzeng, Nian-Sheng [2 ,5 ]
机构
[1] Triserv Gen Hosp, Natl Def Med Ctr, Beitou Branch, Dept Psychiat, Taipei, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan
[3] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pathol, Taipei, Taiwan
[4] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pediat, Taipei, Taiwan
[5] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan
关键词
IFN-BETA-1A; THERAPY; PATIENT;
D O I
10.1097/MJT.0000000000001017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:E627 / E629
页数:4
相关论文
共 50 条
  • [21] Interferon-β treatment for multiple sclerosis
    Bermel, Robert A.
    Rudick, Richard A.
    NEUROTHERAPEUTICS, 2007, 4 (04) : 633 - 646
  • [22] Interferon-β treatment for multiple sclerosis
    Robert A. Bermel
    Richard A. Rudick
    Neurotherapeutics, 2007, 4 : 633 - 646
  • [23] Rapid-onset central motor plasticity in multiple sclerosis
    Zeller, D.
    Kampe, K. aufm
    Biller, A.
    Stefan, K.
    Gentner, R.
    Schuetz, A.
    Bartsch, A.
    Bendszus, M.
    Toyka, K. V.
    Rieckmann, P.
    Classen, J.
    NEUROLOGY, 2010, 74 (09) : 728 - 735
  • [24] Neuropsychological effects of Avonex® (interferon-β-1a) in relapsing multiple sclerosis (MS)
    Fischer, JS
    Priore, R
    Jacobs, L
    Cookfair, D
    Rudick, R
    Herndon, R
    Richert, J
    Salazar, A
    Goodkin, D
    Granger, C
    Simon, J
    Grafman, J
    Lezak, M
    O'Reilly, K
    Schacter, M
    Shucard, D
    Davidson, A
    Wende, K
    NEUROLOGY, 1998, 50 (04) : A32 - A33
  • [25] Dermal fibrosis and cutaneous necrosis after recombinant interferon-β1a injection in a multiple sclerosis patient
    Ozden, MG
    Erel, A
    Erdem, O
    Oztas, MO
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (01) : 112 - 113
  • [26] The PRISMS study.: Interferon-β 1a (Rebif®) in intermittent multiple sclerosis
    Hartung, HP
    Flachenecker, P
    Weilbach, FX
    Rieckmann, P
    NERVENARZT, 1999, 70 (02): : 182 - 185
  • [28] Treatment of multiple sclerosis with beta-interferon 1a
    Rivera, VM
    REVISTA DE NEUROLOGIA, 2000, 31 (05) : 470 - 471
  • [29] Affinity maturation of antibodies against interferon-β in patients with multiple sclerosis treated with interferon β-1a
    Basuroski, I. Dujmovic
    Deisenhammer, F.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S244 - S245
  • [30] Interferon-beta 1a in the treatment of multiple sclerosis
    Hartung, HP
    NERVENARZT, 1997, 68 (06): : 525 - 527